Sagimet Biosciences Inc. (SGMT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 107.72M | 116.4M | 119.23M | 127.2M | 146.07M | 152.77M | 157.19M | 166.75M | 194.49M | 96.65M | 102.82M | 21.35M |
| Cash & Short-Term Investments | 104.54M | 113.12M | 116.69M | 125.41M | 144.57M | 151.25M | 152.49M | 166.37M | 193.71M | 94.9M | 101.84M | 18.51M |
| Cash Only | 36.63M | 35.02M | 32.5M | 42.33M | 64.72M | 75.84M | 77.01M | 95.96M | 176.78M | 75.14M | 101.84M | 18.51M |
| Short-Term Investments | 67.91M | 78.1M | 84.2M | 83.08M | 79.85M | 75.41M | 75.47M | 70.41M | 16.93M | 19.76M | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.18M | 3.28M | 253K | 793K | 888K | 463K | 407K | 130K | 108K | 397K | 77K | 2.74M |
| Total Non-Current Assets | 39K | 78K | 9.17M | 10.21M | 100K | 7.49M | 17.59M | 22.27M | 37K | 73K | 109K | 144K |
| Property, Plant & Equipment | 39K | 78K | 115K | 152K | 38K | 77K | 114K | 151K | 37K | 73K | 109K | 144K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | 15.81x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 8.81M | 10.06M | 0 | 7.41M | 17.47M | 22.12M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 247K | 0 | 62K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 107.75M | 116.48M | 128.4M | 137.41M | 146.17M | 160.26M | 174.78M | 189.02M | 194.53M | 96.72M | 102.92M | 21.5M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | 0.03x | - |
| Asset Growth % | -26.28% | -27.32% | -26.53% | -27.31% | -24.86% | 65.7% | 69.81% | 779.24% | 613.79% | 192.81% | - | - |
| Total Current Liabilities | 5.3M | 5.1M | 9.15M | 7.25M | 7.18M | 4.45M | 4.09M | 5.73M | 4.51M | 5.65M | 5.05M | 5.29M |
| Accounts Payable | 2.3M | 1.31M | 4.24M | 1.92M | 3.22M | 1.43M | 1.15M | 1.99M | 531K | 186K | 1.7M | 2.72M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 39K | 78K | 115K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.96M | 3.71M | 3.5M | 1K | 16K | 5K | 11K | 10K | 0 | 556K | 95K | 103K |
| Current Ratio | 20.34x | 22.82x | 13.04x | 17.55x | 20.34x | 34.30x | 38.41x | 29.11x | 43.12x | 17.09x | 20.36x | 4.04x |
| Quick Ratio | 20.34x | 22.82x | 13.04x | 17.55x | 20.34x | 34.30x | 38.41x | 29.11x | 43.12x | 17.09x | 20.36x | 4.04x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 214.63M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 214.63M |
| Total Liabilities | 5.3M | 5.1M | 9.15M | 7.25M | 7.18M | 4.45M | 4.09M | 5.73M | 4.51M | 5.65M | 5.05M | 219.91M |
| Total Debt | 39K | 78K | 115K | 152K | 39K | 78K | 116K | 153K | 26K | 65K | 103K | 140K |
| Net Debt | -36.59M | -34.94M | -32.38M | -42.17M | -64.68M | -75.76M | -76.9M | -95.81M | -176.75M | -75.07M | -101.74M | -18.37M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 102.46M | 111.38M | 119.25M | 130.16M | 138.99M | 155.81M | 170.68M | 183.29M | 190.02M | 91.06M | 97.88M | -198.41M |
| Equity Growth % | -26.28% | -28.51% | -30.13% | -28.99% | -26.85% | 71.09% | 74.39% | 192.38% | 766.59% | 148.71% | - | - |
| Book Value per Share | 3.15 | 3.44 | 3.67 | 4.04 | 4.32 | 4.84 | 5.31 | 5.74 | 6.54 | 5.01 | 5.38 | -8.95 |
| Total Shareholders' Equity | 102.46M | 111.38M | 119.25M | 130.16M | 138.99M | 155.81M | 170.68M | 183.29M | 190.02M | 91.06M | 97.88M | -198.41M |
| Common Stock | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 2K | 2K | 1K |
| Retained Earnings | -357M | -346.35M | -336.78M | -323.87M | -313.49M | -295.31M | -279.11M | -264.49M | -256.37M | -249.74M | -241.59M | -235.24M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 8K | 120K | 117K | 76K | 121K | 230K | 441K | -23K | 7K | 30K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |